lobbying_activities: 1664509

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1664509	da334a38-6c9f-46d1-bf26-0aadcb328d2e	Q1	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	401103605	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	2015	first_quarter	MED	HR 3631 - Small Manufacturer Protection Act - gives FDA Commissioner authority to issues small business waivers and reductions for User Fees under the Generic Drug User Fee Amendments (GDUFA) S. 3187 - Food and Drug Administration Safety and Innovation Act (FDASIA) - discussed reauthorization of Generic Drug User Fee Amendment after initial five-year period	HOUSE OF REPRESENTATIVES,SENATE		20000	0	0	2015-04-16T14:29:52.107000-04:00